口腔健康研究中的设计与分析特别工作组：颌骨药物相关性骨坏死
Task Force on Design and Analysis in Oral Health Research: Medication-Related Osteonecrosis of the Jaw.
作者信息
Ruggiero S, Saxena D, Tetradis S, Aghaloo T, Ioannidou E
机构信息
1 New York Center for Orthognathic and Maxillofacial Surgery, New York, NY, USA.
2 Stony Brook School of Dental Medicine, Stony Brook, NY, USA.
出版信息
JDR Clin Trans Res. 2018 Jul;3(3):222-225. doi: 10.1177/2380084418770662. Epub 2018 Apr 12.
Abstract
Knowledge Transfer Statement: This article discusses the proceedings of the conference organized by the Task Force on Design and Analysis in Oral Health Research on the understanding of the translational evidence on the etiology and pathogenesis of medication-related osteonecrosis of the jaw as well as the clinical protocols on patient management.
摘要
知识转移声明
本文讨论了口腔健康研究设计与分析特别工作组组织的会议议程，内容涉及对颌骨药物性骨坏死病因和发病机制的转化证据的理解以及患者管理的临床方案。
相似文献
1
Task Force on Design and Analysis in Oral Health Research: Medication-Related Osteonecrosis of the Jaw.口腔健康研究中的设计与分析特别工作组：颌骨药物相关性骨坏死
JDR Clin Trans Res. 2018 Jul;3(3):222-225. doi: 10.1177/2380084418770662. Epub 2018 Apr 12.
2
The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.药物性颌骨坏死的发生率及其相关危险因素。
Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):509-16. doi: 10.1016/j.coms.2015.06.003. Epub 2015 Sep 9.
3
[Position paper on medication-related osteonecrosis of the jaw (MRONJ)].[关于药物性颌骨坏死（MRONJ）的立场文件]
Wien Med Wochenschr. 2016 Feb;166(1-2):68-74. doi: 10.1007/s10354-016-0437-2.
4
CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.抗吸收剂相关性颌骨坏死/药物相关性颌骨坏死的 CT 影像学特征。
Dentomaxillofac Radiol. 2018 May;47(4):20170323. doi: 10.1259/dmfr.20170323. Epub 2018 Feb 13.
5
Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.药物相关性颌骨坏死：双膦酸盐治疗患者与抗吸收-抗血管生成药物治疗患者的风险因素
Minerva Stomatol. 2017 Aug;66(4):135-140. doi: 10.23736/S0026-4970.17.04056-0. Epub 2017 May 10.
6
[Recent treatment for medication-related osteonecrosis of the jaw].[颌骨药物相关性骨坏死的近期治疗]
Clin Calcium. 2016 Apr;26(4):612-21.
7
Histologic analysis of medication-related osteonecrosis of the jaw compared with antiresorptive-exposed bone and other infectious, inflammatory, and necrotic jaw diseases.药物相关性颌骨坏死的组织学分析与抗吸收药物暴露性骨及其他感染性、炎症性和坏死性颌骨疾病的比较。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Feb;129(2):133-140. doi: 10.1016/j.oooo.2019.08.018. Epub 2019 Sep 3.
8
Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.药物相关性颌骨坏死的诊断与分期
Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):479-87. doi: 10.1016/j.coms.2015.06.008. Epub 2015 Aug 18.
9
[Progress on medication-related osteonecrosis of the jaw].[颌骨药物相关性骨坏死的研究进展]
Hua Xi Kou Qiang Yi Xue Za Zhi. 2018 Oct 1;36(5):568-572. doi: 10.7518/hxkq.2018.05.019.
10
Pathophysiology of Osteonecrosis of the Jaws.颌骨骨坏死的病理生理学
Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):489-96. doi: 10.1016/j.coms.2015.06.001. Epub 2015 Sep 26.
引用本文的文献
1
Effect of Bacterial Nanocellulose with Chemisorbed Antiseptics on Alveolar Bone Repair in Rats Undergoing Bisphosphonate Therapy.化学吸附防腐剂的细菌纳米纤维素对接受双膦酸盐治疗的大鼠牙槽骨修复的影响。
Pharmaceutics. 2024 Dec 26;17(1):24. doi: 10.3390/pharmaceutics17010024.
2
Bisphosphonate-Related Osteonecrosis of the Jaw and Oral Microbiome: Clinical Risk Factors, Pathophysiology and Treatment Options.颌骨骨坏死与口腔微生物组：双膦酸盐相关性、临床危险因素、病理生理学和治疗选择。
Int J Mol Sci. 2024 Jul 24;25(15):8053. doi: 10.3390/ijms25158053.
3
Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab.与接受地舒单抗治疗的患者发生药物相关性颌骨坏死相关的风险因素。
Clin Oral Investig. 2022 Mar;26(3):2839-2852. doi: 10.1007/s00784-021-04261-4. Epub 2021 Nov 23.
4
Conservative non-surgical management in medication related osteonecrosis of the jaw: A retrospective study.药物相关性颌骨骨坏死的保守非手术治疗：一项回顾性研究。
Clin Exp Dent Res. 2020 Oct;6(5):512-518. doi: 10.1002/cre2.303. Epub 2020 Jul 2.
本文引用的文献
1
Pathophysiology of Osteonecrosis of the Jaws.颌骨骨坏死的病理生理学
Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):489-96. doi: 10.1016/j.coms.2015.06.001. Epub 2015 Sep 26.
2
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.颌骨骨坏死的诊断和治疗：系统评价和国际共识。
J Bone Miner Res. 2015 Jan;30(1):3-23. doi: 10.1002/jbmr.2405.
3
American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.美国口腔颌面外科医师协会关于药物相关性颌骨坏死的立场文件——2014年更新版
J Oral Maxillofac Surg. 2014 Oct;72(10):1938-56. doi: 10.1016/j.joms.2014.04.031. Epub 2014 May 5.
4
Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw.口腔微生物群与双膦酸盐相关颌骨坏死中的宿主固有免疫反应。
Int J Oral Sci. 2014 Dec;6(4):219-26. doi: 10.1038/ijos.2014.46. Epub 2014 Aug 8.
5
Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model.抗吸收治疗的小鼠上颌骨自发性颌骨骨坏死：一种新型ONJ小鼠模型
Bone. 2014 Nov;68:11-9. doi: 10.1016/j.bone.2014.07.027. Epub 2014 Aug 2.
6
Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.根尖周病和双膦酸盐可诱导小鼠颌骨坏死。
J Bone Miner Res. 2013 Jul;28(7):1631-40. doi: 10.1002/jbmr.1894.
Zotero 插件